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Intimal hyperplasia remains a significant clinical problem in for example coronary
artery bypass graft failure. Since omega-3 fatty acids reduce intimal hyperplasia,
we hypothesized that the G protein-coupled receptor ChemR23 for the omega-3-
derived pro-resolving lipid mediator resolvin E1 drives those effects. ChemR23+/+ and
ChemR23−/− mice were generated with or without introduction of the Caenorhabditis
elegans fat-1 transgene, which leads to an endogenous omega-3 fatty acid
synthesis and thus increasing the substrate for resolvin E1 formation. ChemR23
deletion significantly increased intimal hyperplasia 28 days after ligation of the
left common carotid artery. Mice expressing the fat-1 transgene showed reduced
intimal hyperplasia independently of ChemR23 expression. ChemR23−/− Vascular
smooth muscle cells (VSMCs) exhibited a significantly lower proliferation compared
with VSMCs derived from ChemR23+/+ mice. In contrast, ChemR23−/− peritoneal
macrophages had significantly higher mRNA levels of pro-inflammatory cytokines
compared with ChemR23+/+ macrophages. Finally, conditioned media (CM) transfer
from ChemR23−/− macrophages to VSMCs significantly increased VSMC proliferation
compared with CM from ChemR23+/+ macrophages. Taken together, these results
point to a dual effect of ChemR23 in resolution pharmacology by directly stimulating
VSMC proliferation and at the same time suppressing macrophage-induced VSMC
proliferation. In conclusion, these differential effects of ChemR23 signaling in VSMC and
macrophages open up a novel notion for intimal hyperplasia pathophysiology, where
ChemR23-transduced effects on the vascular wall may vary, and even be opposing,
depending on the degrees of resolution of inflammation.
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INTRODUCTION
The effectiveness of drug eluting stents for the prevention
of restenosis after percutaneous coronary interventions (PCI)
relies on the potent effects of cell cycle inhibitors on vascular
smooth muscle cell (VSMC) proliferation (Bäck and Hansson,
2015). Intimal hyperplasia, however, remains a significant clinical
problem in for example coronary artery bypass graft failure
(Wadey et al., 2018). In addition to direct effects on VSMCs,
intimal hyperplasia is also driven by inflammation, by means of
neutrophil, and macrophage infiltration, as well as cytokine and
matrix metalloproteinase (MMP) release (Wadey et al., 2018). In
particular, a failure in the resolution of the acute inflammatory
response to vascular injury prevents re-endotheliazation and
promotes VSMC proliferation and migration (Wu et al., 2017).
Omega-3 fatty acids decrease inflammation (Serhan, 2014),
and inhibit intimal hyperplasia in mice (Li et al., 2015). Other
studies have shown similar effects after administration of the
pro-resolving lipid mediators resolvins and maresins, which
are enzymatically formed from omega-3 fatty acids (Ho et al.,
2010; Akagi et al., 2015; Liu et al., 2018; Wu et al., 2018).
The latter studies provided the initial evidence that stimulating
the resolution of inflammation by means of lipid pro-resolving
mediators would promote an adequate healing of vascular
injury. However, the receptor(s) involved in this protective
effects in vivo remain unknown. We recently established a
protective role for the G protein-coupled receptor ChemR23
for the omega-3-derived pro-resolving lipid mediator resolvin
E1 in atherosclerosis (Laguna-Fernandez et al., 2018), but its
implications for intimal hyperplasia have remained hitherto
unexplored. The aim of the present study was therefore to
establish the role of ChemR23 in the downstream signaling of
omega-3 fatty acids in intimal hyperplasia, in a pro-inflammatory
vascular injury murine model (Zhang et al., 2008).
METHODS
Carotid Ligation
The study was approved by the Regional Ethical Review Board
in Stockholm. All animals used were male and on a C57BL/6J
background. ChemR23−/− mice were obtained from Deltagen.
Mice expressing the Caenorhabditis elegans fat-1transgene were
bred as previously described (Lopez-Vicario et al., 2015).
The two mice strains were then crossbred to generate four
groups; ChemR23+/+, ChemR23−/−, fat-1/ChemR23+/+, and
fat-1/ChemR23−/−. 10 weeks old littermates (n = 6–8/group)
were subjected to a complete left carotid ligation as previously
described (Petri et al., 2015b) and indicated in Figure 1A. In
brief, the four groups were fed in a 10% v/w Omega-6 (Sigma-
aldrich, S8281) enriched diet to increase the fat-1 desaturase
substrate. EPA and DHA were quantified by gas chromatography
as a control as previously described (Laguna-Fernandez et al.,
2018), and exhibited the expected increase in fat-1 transgenic
mice independently of ChemR23 expression (data not shown).
After 7 days, mice were anesthetized with isoflurane/O2 (2:1)
followed by 0.1 mg s.c. injection of buprenorphine for pain
relief. Left common carotid artery was exposed, followed by
a complete ligation at the bifurcation level with a 7-0 suture.
After 28 days from ligation, mice were euthanized by CO2,
PFA fixated, and the ligated carotid was collected in PFA, and
paraffin embedded. For carotid intimal hyperplasia evaluation,
8 sections of 10 um each every 100 um, were collected. Next,
H&E staining was performed to assess neointimal growth area
at the site of ligation. Furthermore, sections were stained with
antibodies (Supplementary Table 1) for rabbit anti α-SMA
(Abcam), rat anti CD206 (Serotec), rat anti Mac2 (Cedarlane),
and rat anti Ly6G (BD) for macrophage and neutrophil content
determination, respectively. Negative and isotype controls are
shown in Supplementary Figure 2. Staining in the neointima
was assessed using the automated software Leica QWin Standard
Y 2.8 (Leica Microsystems) and normalized to neointima area.
Rat and rabbit isotype controls were purchased from R&D, and
Abcam, and secondary antibodies from Vector.
VSMC Isolation and Evaluation of
Proliferation
Abdominal aortas from ChemR23+/+ and ChemR23−/− mice
(n = 3/group) were isolated, fat and adventitia removed, and
digested in a sterile mixture of 1 mg/mL collagenase type II
(Worthington) and 0.3 mg/mL elastase (Sigma, E0127) in DMEM
with 10% FBS for 90 min at 37◦C and 5% CO2. Cell suspension
was spun down, resuspended in complete medium (DMEM, 10%
fetal calf serum, 100 units/ml penicillin, 100 µg/ml streptomycin,
1 mM sodium pyruvate, 10 mM HEPES, and 2 mM L-glutamine)
and plated. Cells were passaged using trypsin when they reached
80% confluency. Proliferation was assessed by WST-1 reagent
(Roche) according to manufacturer’s protocol.
Peritoneal Macrophages Conditioned
Media Generation
Peritoneal macrophages from ChemR23+/+ and ChemR23−/−
mice (n = 4/group) were obtained as previously described
(Laguna-Fernandez et al., 2018). Macrophages were treated for
24 h with complete medium supplemented with LPS (100 ng/ml),
washed and followed by a 24 h incubation in complete medium
without LPS. After that, cell supernatant was collected and
frozen. After thawing, supernatants were diluted 1:10 in complete
medium and transferred to ChemR23+/+ VSMCs.
RNA Extraction and Real-Time PCR
RNA from ChemR23+/+ and ChemR23−/− peritoneal
macrophages was isolated after 24 h of LPS (100 ng/ml)
stimulation using the RNeasy Mini Kit (Qiagen). RNA
concentration was quantified by Nanodrop (Thermo Scientific).
Relative gene expression was assessed using Taqman assays
from Life Technologies: GAPDH as endogenous control
(Mm99999915), TNF-α (Mm00443258), IL-6 (Mm00443258),
MMP9 (Mm00442991), IL-1β (Mm00434228), and IL-10
(Mm01288386).
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FIGURE 1 | ChemR23 deletion promotes intimal hyperplasia under pro-inflammatory conditions. (A) Schematic representation of in vivo experimental procedure.
(B) Mouse intima hyperplasia quantification in: ChemR23+/+ n = 7, ChemR23−/− n = 7, fat-1tg ChemR23+/+ n = 6, fat-1tg ChemR23−/− n = 8; after left common
carotid ligation, and representative H&E stained photomicrographs. (C) Ly6G+ (neutrophil) ChemR23+/+ n = 5, ChemR23−/− n = 7 and Mac-2 (macrophage)
ChemR23+/+ n = 4, ChemR23−/− n = 7 immunohistochemistry quantification, and representative photomicrographs. Data represent mean ± SEM. P-values derive
from (B) 2-way ANOVA, (C) Student’s t-test.
FIGURE 2 | ChemR23 deletion alters the Vascular smooth muscle cells (VSMC) and macrophage phenotype. (A) Basal ChemR23+/+ and ChemR23−/− VSMC
proliferation (48h) in vitro, assessed by WST-1. (B) mRNA expression of LPS-activated (100 ng/mL, 24 h) peritoneal macrophages in vitro. (C) VSMC proliferation
(48 h) treated with conditioned media (CM) derived from LPS-activated ChemR23+/+ and ChemR23−/− macrophages. For VSMC n = 3/group, for macrophages
n = 4/group. Data represent mean ± SEM. P-values derive from Student’s t-test.
Statistics
Results are expressed as mean ± S.E.M. Statistical significance
was assigned at p < 0.05 as assessed with Student t-test
when comparing two groups, and with two-way ANOVA as
appropriate followed by recommended post hoc tests, for multiple
comparisons. All analyses were performed using GraphPad Prism
7 (GraphPad Software Inc., CA, United States).
RESULTS
We here report for the first time that genetic disruption
of ChemR23 significantly increased intimal hyperplasia
(Figure 1B). Furthermore, and as predicted, mice expressing
the Caenorhabditis elegans fat-1 transgene, which enables
the endogenous production of omega-3 fatty acids, exhibited
reduced intimal hyperplasia (Figure 1B). Crossbreeding of
the two models also allowed us to determine the interaction
between the observed effects attributed to omega-3 fatty acids
and ChemR23, respectively. Unexpectedly, the fat-1 transgene
was protective in both ChemR23+/+ and ChemR23−/−
mice (Figure 1B). Immunohistochemistry in intimal lesions
revealed an infiltration of neutrophil granulocytes (Ly6G) and
macrophages (Mac-2), which were not significantly different
between ChemR23+/+ and ChemR23−/− mice (Figure 1C),
whereas no T-lymphocyte infiltration (CD3) was detected (data
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not shown). Analysis of CD206, as a marker of M2 macrophages,
revealed no significant differences between ChemR23+/+ and
ChemR23−/− mice in the percentage of CD206 positive cells
in the intima (1,52 ± 0,47, 1.26 ± 0.38, p = 0.682), nor in
the ratio between M2 and total macrophages (CD206/Mac-2)
(31.17 ± 9.66, 40.98 ± 12.30, p = 0.538) (Supplementary
Figure 1A). Finally, intimal lesions stained positive for α-smooth
muscle actin, but revealed no differences in the percentage of
α-smooth muscle actin in the intima between ChemR23+/+ and
ChemR23−/− mice (Supplementary Figure 1B).
To decipher the mechanisms involved in the phenotype
associated with ChemR23-deficiency, we subsequently
isolated abdominal aortic VSMCs from ChemR23+/+
and ChemR23−/− mice. ChemR23−/− VSMCs exhibited
significantly less proliferation compared with ChemR23+/+
VSMCs (Figure 2A). These in vitro findings were hence in
sharp contrast to the increased intimal hyperplasia observed in
ChemR23-deficient mice in vivo. To further characterize the
ChemR23-dependent phenotype, we subsequently studied
the inflammatory response in LPS-activated peritoneal
macrophages, isolated from ChemR23+/+ and ChemR23−/−
mice. ChemR23−/− macrophages exhibited a more pro-
inflammatory phenotype, with significantly higher mRNA levels
of TNFα, and MMP9 (Figure 2B). These results indicated
that in intimal hyperplasia, ChemR23−/− VSMCs may
have a protective phenotype (less proliferation), whereas
ChemR23−/− macrophages would be detrimental (increased
inflammation). To assess the consequences of the differential
macrophage phenotypes on VSMC proliferation, VSMCs were
treated with CM derived from LPS-activated ChemR23+/+
and ChemR23−/− macrophages, respectively. ChemR23−/−
macrophage CM significantly increased VSMC proliferation
as compared with VSMC treated with ChemR23+/+ media
(Figure 2C).
DISCUSSION
Three major observations emerge from the present study.
First, our results revealed a protective role of ChemR23 in
intimal hyperplasia, which was unrelated to the beneficial
effects of enriching tissues with omega-3. Secondly, we identify
ChemR23 as a transducer of opposing effects in different
cell types, in terms of suppressing inflammatory activation
of macrophages, but stimulating proliferation of VSMCs.
Third, ChemR23−/− macrophages in turn promoted VSMC
proliferation. Taken together, these results suggest that ChemR23
signaling toward the resolution of inflammation protects
from intimal hyperplasia by means of reducing macrophage
activation.
The observation that genetic ChemR23 deletion increased
the inflammatory response in macrophages supports previous
reports (Cash et al., 2014; Lopez-Vicario et al., 2017) and is
consistent with our recent findings that ChemR23 deletion
in hyperlipidemic mice accelerated atherosclerosis (Laguna-
Fernandez et al., 2018). The present study extends that
observation by showing that a failure in the resolution of
macrophage-induced inflammation by means of ChemR23
deficiency increased VSMC proliferation. This effect was
independent of an increased total number of macrophages or
M2 macrophage subtype. In accordance with this findings,
in atherosclerotic lesions ChemR23 expressing macrophages
do not correspond to an M2 phenotype (Laguna-Fernandez
et al., 2018). Indeed, previous results indicate that ChemR23
expression in M1 macrophages acts to promote the resolution
of inflammation (Herova et al., 2015). Altogether the expression
of ChemR23 in both macrophages and smooth muscle cells
in human atherosclerotic lesions (Laguna-Fernandez et al.,
2018), support an extrapolation of these results to human
pathophysiology.
Previous reports have shown that pro-resolving lipid
mediators decrease VSMC proliferation (Wu et al., 2018),
and that VSMC lacking the lipoxin, and D-resolvin receptor
ALX/FPR2 exhibit decreased migration (Petri et al., 2015b).
In the present study, however, ChemR23 deficient VSMCs
proliferated less compared with wild-type VSMCs. Hence, in the
absence of a macrophage-derived response, ChemR23 signaling
may in contrast promote VSMC proliferation. These observations
suggest that while ChemR23 signals to limit macrophage-induced
inflammation, ChemR23 may transduce deleterious effects on
VSMCs under non-inflammatory conditions. Whether different
agonists transduce those differential responses, however, remains
to be established. In general, pro-resolving agonists are associated
with a beneficial smooth muscle response in vascular injury (Ho
et al., 2010; Wu et al., 2018), abdominal aortic aneurysms (Pope
et al., 2016; Petri et al., 2018) and atherosclerosis (Viiri et al.,
2013; Petri et al., 2015a).
The reduced intimal hyperplasia by ChemR23 appeared
independently of the beneficial effects of omega-3 fatty acids,
and suggest ChemR23 expression being directly coupled to the
VSMC, and macrophage phenotypes. Other studies have indeed
implicated signaling through the free fatty acid receptor-4 to
mediate beneficial effects of omega-3 fatty acids in and murine
models of intimal hyperplasia (Li et al., 2015).
In conclusion, the opposing effects of ChemR23 on VSMC and
macrophages reported in the present study raise a novel notion
for intimal hyperplasia pathophysiology, namely that the same
receptor may transduce both protective and deleterious effects,
which may vary over time depending on different stages in the
resolution of inflammation.
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